GENE ONLINE|News &
Opinion
Blog

mRNA
Canada Signs Deal with Moderna to Build Vaccine Plant in the Country
2021-08-12
With Increasing Appeal for RNA Technology, Medford Startup Jumps on the SPAC Wagon to Go Public
2021-08-10
Moderna Banks on Autolus’ Proprietary Tech to Advance Immuno-Oncology Pipeline
2021-08-03
Korea’s Local Pharmas Unite to Strengthen mRNA Vaccine Production
2021-06-03
Pick your Potion, An Overview of the COVID Vaccines
2020-12-31
Moderna’s COVID-19 Vaccine Bags FDA’s Emergency Use Authorization, Inoculations to Start on Monday
2020-12-19
Singapore Becomes First Country in Asia Pacific to Greenlight Pfizer/BioNTech’s COVID-19 Vaccine
2020-12-16
Final Analysis Suggests Pfizer, BioNTech’s COVID-19 Vaccine is Safe with 95% Efficacy
2020-11-18
Moderna Gives Updates on Its Diversified Pipeline at R&D Day
2020-09-19
CureVac Shares Catapult 494% Following Successful IPO Debut
2020-08-18
Arrakis Signs Lucrative Deal with Roche to Develop RNA Targeting Small Molecules
2020-04-09
June 6, 1944: American Geneticist and Molecular Biologist Phillip Sharp Was Born
2018-06-06
1 2 3
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top